A rapid RP-HPLC method for the simultaneous estimation of Ivacaftor and Tezacaftor and in silico study of their metabolitic products
Abstract Background This study was designed to develop a reliable method for estimation of Ivacaftor and Tezacaftor in pure and its pharmaceutical dosage form by RP-HPLC in human plasma. Molecular docking studies were carried out and the results were visualized using PyMol and Discovery studio visua...
Saved in:
Main Authors: | Madhuri Donakonda (Author), Srija Indrakanti (Author), Praveen Kumar Pasala (Author), Malleswari Desari (Author), Shireesha Kammari (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efectividad de TEZACAFTOR/IVACAFTOR+IVACAFTOR en fibrosis quística
by: Paula Del Río Ortega
Published: (2022) -
Efectividad de TEZACAFTOR/IVACAFTOR+IVACAFTOR en fibrosis quística
by: Paula Del Río Ortega
Published: (2022) -
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor
by: Burkhard Tümmler, et al.
Published: (2023) -
Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor
by: Varun Garg, et al.
Published: (2019) -
Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
by: Shiferaw D, et al.
Published: (2019)